Oral Oncology
Journal Abbreviation: ORAL ONCOL
ISSN: 1368-8375
Publisher: Elsevier
Publications (14)
ATR inhibition in combination with hypofractionated radiotherapy is superior to ATM inhibition with regard to ex vivo CD8 + T cell activation particularly for HPV-negative head and neck cancer cells (2026)
Schäfer A, Zülch L, Steinsdörfer L, Donaubauer AJ, Reichardt C, Frey B, Fietkau R, et al.
Journal article
Systematic classification of confocal laser endomicroscopy for the diagnosis of oral cavity carcinoma (2022)
Sievert M, Oetter N, Mantsopoulos K, Gostian AO, Müller SK, Koch M, Balk M, et al.
Journal article
Salvage total glossectomy and total glosso-laryngectomy: Are they worth it? A GETTEC French multicenter study. (2022)
Mazerolle P, Fuchsmann C, Schultz P, Benmoussa N, Malard O, Bozec A, Deneuve S, et al.
Journal article
Precautionary documents in patients with head and neck cancer - status quo and factors influencing their creation (2021)
Allner M, Gostian M, Balk M, Rupp R, Hecht M, Ostgathe C, Müller SK, et al.
Conference contribution
Time dependency of adjuvant therapy in advanced head-and-necksquamous-cell-carcinoma of unknown primary (CUP)-patients (2021)
Balk M, Rupp R, Grundtner P, Müller SK, Allner M, Traxdorf M, Eckstein M, et al.
Conference contribution
Satellite nodules in pleomorphic adenomas of the parotid gland: A nightmare for less invasive parotid surgery? (2021)
Iro AK, Agaimy A, Müller SK, Sievert M, Iro H, Mantsopoulos K
Journal article
Tumour spillage of the pleomorphic adenoma of the parotid gland: A proposal for intraoperative measures (2021)
Mantsopoulos K, Iro H
Journal article
Lymphatic and vascular invasion in oral squamous cell carcinoma: Implications for recurrence and survival in a population-based cohort study (2020)
Spoerl S, Gerken M, Fischer R, Mamilos A, Spoerl S, Wolf S, Pohl F, et al.
Journal article
Complex midfacial defects: Is the extended Abbé flap the ideal solution to a tough problem? (2020)
Mantsopoulos K, Iro H, Constantinidis J
Journal article
Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1) (2020)
Semrau S, Schmidt D, Hecht M, Haderlein M, Kitzsteiner C, Müller S, Traxdorf M, et al.
Journal article